Kidney Cortical Transporter Expression across Species Using Quantitative Proteomics

被引:67
作者
Basit, Abdul [1 ]
Radi, Zaher [2 ]
Vaidya, Vishal S. [2 ]
Karasu, Matthew [1 ]
Prasad, Bhagwat [1 ]
机构
[1] Univ Washington, Dept Pharmaceut, POB 357610, Seattle, WA 98195 USA
[2] Pfizer Worldwide Res Dev, Drug Safety Res Dev, Cambridge, MA USA
关键词
DRUG TRANSPORTERS; CREATININE; TENOFOVIR; ABUNDANCE; NEPHROTOXICITY; VARIABILITY; CLEARANCE; CISPLATIN; TOXICITY; PROTEIN;
D O I
10.1124/dmd.119.086579
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Limited understanding of species differences in kidney transporters is a critical knowledge gap for prediction of drug-induced acute kidney injury, drug interaction, and pharmacokinetics in humans. Here, we report protein abundance data of 19 transporters in the kidney cortex across five species (human, monkey, dog, rat, and mouse). In general, the abundance of all of the 19 membrane transporters was higher in preclinical species compared with human except for multidrug resistance protein 1 (MDR1), organic cation transporter (OCT) 3, and OCTN1. In nonhuman primate, the total abundance of 12 transporters for which absolute data were available was 2.1-fold higher (P = 0.025) relative to human but the percentage of distribution of these transporters was identical in both species. Multidrug resistance-associated protein (MRP) 4, OCTN2, organic anion transporter (OAT) 2, sodium/potassium-transporting ATPase, MRP3, SGLT2, OAT1, MRP1, MDR1, and OCT2 were expressed differently with cross-species variabilities of 8.2-, 7.4-, 6.1-, 5.9-, 5.4-, 5.2-, 4.1-, 3.3-, and 2.8-fold, respectively. Sex differences were only significant in rodents and dog. High protein-protein correlation was observed in OAT1 versus MRP2/MRP4 as well as OCT2 versus MATE1 in human and monkey. The cross-species and sex-dependent protein abundance data are important for animal to human scaling of drug clearance as well as for mechanistic understanding of kidney physiology and derisking of kidney toxicity for new therapeutic candidates in drug development.
引用
收藏
页码:802 / 808
页数:7
相关论文
共 25 条
  • [1] Age- and Genotype-Dependent Variability in the Protein Abundance and Activity of Six Major Uridine Diphosphate-Glucuronosyltransferases in Human Liver
    Bhatt, Deepak Kumar
    Mehrotra, Aanchal
    Gaedigk, Andrea
    Chapa, Revathi
    Basit, Abdul
    Zhang, Haeyoung
    Choudhari, Prachi
    Boberg, Mikael
    Pearce, Robin E.
    Gaedigk, Roger
    Broeckel, Ulrich
    Leeder, J. Steven
    Prasad, Bhagwat
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (01) : 131 - 141
  • [2] Critical Issues and Optimized Practices in Quantification of Protein Abundance Level to Determine Interindividual Variability in DMET Proteins by LC-MS/MS Proteomics
    Bhatt, Deepak Kumar
    Prasad, Bhagwat
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (04) : 619 - 630
  • [3] Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: A resource for investigations into drug disposition
    Bleasby, K.
    Castle, J. C.
    Roberts, C. J.
    Cheng, C.
    Bailey, W. J.
    Sina, J. F.
    Kulkarni, A. V.
    Hafey, M. J.
    Evers, R.
    Johnson, J. M.
    Ulrich, R. G.
    Slatter, J. G.
    [J]. XENOBIOTICA, 2006, 36 (10-11) : 963 - 988
  • [4] Breljak D, 2010, HISTOL HISTOPATHOL, V25, P1385, DOI 10.14670/HH-25.1385
  • [5] The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis
    Bush, Kevin T.
    Wu, Wei
    Lun, Christina
    Nigam, Sanjay K.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (38) : 15789 - 15803
  • [6] Effects of gender on the pharmacokinetics of drugs secreted by the renal organic anions transport systems in the rat
    Cerrutti, JA
    Quaglia, NB
    Brandoni, A
    Torres, AM
    [J]. PHARMACOLOGICAL RESEARCH, 2002, 45 (02) : 107 - 112
  • [7] Transporters affecting biochemical test results: Creatinine-drug interactions
    Chu, X.
    Bleasby, K.
    Chan, G. H.
    Nunes, I.
    Evers, R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (05) : 437 - 440
  • [8] Effect of diabetes on biodistribution, nephrotoxicity and antitumor activity of cisplatin in mice
    da Silva Faria, Marcia C.
    dos Santos, Neife A. G.
    Carvalho Rodrigues, Maria A.
    Rodrigues, Jairo Lisboa
    Barbosa Junior, Fernando
    dos Santos, Antonio Cardozo
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2015, 229 : 119 - 131
  • [9] Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced Nephrotoxicity
    Filipski, K. K.
    Mathijssen, R. H.
    Mikkelsen, T. S.
    Schinkel, A. H.
    Sparreboom, A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (04) : 396 - 402
  • [10] Solute carrier transporter and drug-related nephrotoxicity: the impact of proximal tubule cell models for preclinical research
    Fisel, Pascale
    Renner, Olga
    Nies, Anne T.
    Schwab, Matthias
    Schaeffeler, Elke
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (03) : 395 - 408